These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 22326683)

  • 41. Inhibition of platelet aggregation by moxalactam and free N-methylthiotetrazole.
    Ingalls CS; Somani P; Freimer EH
    Clin Ther; 1989; 11(5):640-51. PubMed ID: 2629724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alteration of release and role of adenosine diphosphate and thromboxane A2 during collagen-induced aggregation of platelets from cattle with Chediak-Higashi syndrome.
    Honda N; Ohnishi K; Fujishiro T; Ikeda M; Ito K
    Am J Vet Res; 2007 Dec; 68(12):1399-406. PubMed ID: 18052747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins.
    Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G
    Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of some antineoplastic drugs (vincristine, doxorubicin and epirubicin) on human platelet aggregation.
    Matera C; Falzarano C; Vacca C; Falciani M; Rossi F
    J Med; 1994; 25(1-2):2-16. PubMed ID: 7930957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitory effect of hexahydrocurcumin on human platelet aggregation.
    Dong HP; Yang RC; Chunag IC; Huang LJ; Li HT; Chen HL; Chen CY
    Nat Prod Commun; 2012 Jul; 7(7):883-4. PubMed ID: 22908571
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anticoagulant and estrogenic effects of two new 17 beta-aminoestrogens, butolame [17 beta-(4-hydroxy-1-butylamino)-1,3,5(10)-estratrien-3-ol] and pentolame [17 beta-(5-hydroxy-1-pentylamino)-1,3,5(10)-estratrien-3-ol].
    Lemini C; Rubio-Póo C; Silva G; García-Mondragón J; Zavala E; Mendoza-Patiño N; Castro D; Cruz-Almanza R; Mandoki JJ
    Steroids; 1993 Oct; 58(10):457-61. PubMed ID: 8256254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tyrame [N-(3-hydroxy-1:3:5(10)-estratrien-17β-yl)-4-hydroxy-phenethylamine], antithrombotic aminoestrogen that decreases microvesicle formation.
    Flores-García M; Fernández-González JM; León-Martínez M; Hernández-Ortega S; Hernández-López JR; Reyes-Munguía D; Sánchez-Sarabia H; Piña-Fragoso Z; Peña-Díaz A
    Gac Med Mex; 2021; 157(6):588-593. PubMed ID: 35108248
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and molecular structure of prolame, N-(3-hydroxy-1,3,5(10)-estratrien-17 beta-yl)-3-hydroxypropylamine; an amino-estrogen with prolonged anticoagulant and brief estrogenic effects.
    Fernández JM; Rubio-Arroyo MF; Soriano-García M; Toscano RA; Pérez-César MC
    Steroids; 1985 Feb; 45(2):151-7. PubMed ID: 3841424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparative structural study of the steroid epimers: 17 beta-amino-1,3,5(10)-estratrien-3-ol, 17 alpha-amino-1,3,5(10)-estratrien-3-ol, and some derivatives by 1H NMR, and x-ray diffraction analysis.
    Lemini C; Cruz-Ramos E; Toscano RA; Cruz-Almanza R
    Steroids; 1998 Nov; 63(11):556-64. PubMed ID: 9830681
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Design, synthesis of novel N, N'-bis-(halogenophenyl)-4- methoxybenzene-1, 3-disulfonamides and evaluation of their anti-platelet aggregation activity].
    Li GA; Wang X; Meng X; Lin YB; Li X; Liu XJ
    Yao Xue Xue Bao; 2015 Feb; 50(2):185-90. PubMed ID: 25975026
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular determinants of the platelet aggregation inhibitory activity of carbamoylpiperidines.
    Feng Z; Gollamudi R; Dillingham EO; Bond SE; Lyman BA; Purcell WP; Hill RJ; Korfmacher WA
    J Med Chem; 1992 Aug; 35(16):2952-8. PubMed ID: 1501222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The anticoagulant effect of prolame, N-(3-hydroxy-1,3,5(10)estratrien-17 beta-yl)-3-hydroxypropylamine, a novel amino-estrogen.
    Rubio-Póo C; Mandoki JJ; Mendoza-Patiño N; Lemini C; de la Peña A; Cruz F; Zavala E; Silva G; Garcia-Mondragón J; Fernández JM
    Steroids; 1985 Feb; 45(2):159-70. PubMed ID: 3841425
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New carbamoylpiperidines as human platelet aggregation inhibitors.
    Guo Z; Zheng X; Thompson W; Dugdale M; Gollamudi R
    Bioorg Med Chem; 2000 May; 8(5):1041-58. PubMed ID: 10882016
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A short efficient synthesis of 16-oxygenated estratriene 3-sulfates.
    Numazawa M; Kimura K; Nagaoka M
    Steroids; 1981 Nov; 38(5):557-65. PubMed ID: 6275576
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The anticoagulant effect of hexolame, N-(3-hydroxy-1,3,5(10)-estratrien-17 beta-yl)-6-hydroxyhexylamine, another amino-estrogen with prolonged anticoagulant effect.
    Rubio-Póo C; Lemini C; García-Mondragón J; de la Peña A; Jayme V; Mendoza-Patiño N; Zavala E; Silva G; Blickenstaff RT; Fernández JM
    Steroids; 1990 Feb; 55(2):83-6. PubMed ID: 2326832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surface activity and human blood platelet aggregation-inhibitory potency.
    Quintana RP; Lasslo A; Queen GS
    Chem Biol Interact; 1982 Jan; 38(2):135-44. PubMed ID: 7055847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [On the relation between steroids and carcinogenic compounds. III. 2-Amino- and 3-amino-4-methyl-Delta1, 3,5(10)-estratrien-17beta-o1].
    DANNENBERG H
    Z Krebsforsch; 1963; 65():396-403. PubMed ID: 14025023
    [No Abstract]   [Full Text] [Related]  

  • 58. Monosubstituted Coumarins Inhibit Epinephrine-induced Platelet Aggregation.
    Jiménez-Orozco FA; Galicia-Zapatero S; López-López E; Medina-Franco JL; Cedeño FL; Flores-García M; Mejia-Domínguez AM; de la Peña-Díaz A
    Cardiovasc Hematol Agents Med Chem; 2022; 20(1):43-51. PubMed ID: 33906594
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of heat and pH treatments and in vitro digestion on the biological activity of protein hydrolysates of
    López-Sánchez J; Ponce-Alquicira E; Pedroza-Islas R; de la Peña-Díaz A; Soriano-Santos J
    J Food Sci Technol; 2016 Dec; 53(12):4298-4307. PubMed ID: 28115770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The structures and inhibitory effects of Buame [N-(3-hydroxy-1,3,5(10)-estratrien-17β-yl)-butylamine] and Diebud [N,N'-bis-(3-hydroxy-1,3,5(10)-estratrien-17β-yl)-1,4-butanediamine] on platelet aggregation.
    Flores-García M; Fernández-G JM; León-Martínez M; Hernández-Ortega S; Pérez-Méndez O; Correa-Basurto J; Carreón-Torres E; Tolentino-López LE; Ceballos-Reyes GM; de la Peña-Díaz A
    Steroids; 2012 Apr; 77(5):512-20. PubMed ID: 22326683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.